Effectiveness of difluprednate in addition to systemic therapy for the treatment of anterior scleritis.
Paulina LibermanJennifer ThorneBryn BurkholderMeghan K BerkenstockPublished in: The British journal of ophthalmology (2023)
Most eyes treated with difluprednate achieved inactivity. The addition of difluprednate to systemic therapies provides an alternative to achieve control of inflammation.